PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | Total Revenue | 5,405,000 | 4,448,000 | 37,184,000 | 33,248,000 | Cost of Revenue |
-
| (5,688,000) | 2,840,000 | 2,848,000 | | Gross Profit | 5,405,000 | 10,136,000 | 34,344,000 | 30,400,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,642,000 | 12,822,000 | 11,237,000 | 12,492,000 | | Non Recurring | 1,196,000 | 9,914,000 | 663,000 | 735,000 | | Others | 7,890,000 | 8,131,000 | 13,068,000 | 9,915,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | Operating Income or Loss | (6,909,000) | 22,738,000 | 9,376,000 | 7,258,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 277,000 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (8,551,000) | 11,839,000 | 9,376,000 | 7,258,000 | | Interest Expense | 6,542,000 | 12,368,000 | 3,948,000 | 4,863,000 | | Income Before Tax | (15,093,000) | (529,000) | 5,428,000 | 2,395,000 | | Income Tax Expense | (7,353,000) | (1,122,000) | 957,000 | 785,000 | | Minority Interest | (71,000) | (74,000) | 34,000 | 16,000 | | | | Net Income From Continuing Ops | (7,740,000) | 543,000 | 4,505,000 | 1,626,000 | | | Non-recurring Events | | Discontinued Operations | 230,000 | (416,000) | (226,000) | (33,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | Net Income | (7,579,000) | 101,000 | 4,279,000 | 1,593,000 | Preferred Stock And Other Adjustments |
-
|
-
| 2,559,000 | (2,559,000) | | Net Income Applicable To Common Shares | ($7,579,000) | $101,000 | $6,838,000 | ($966,000) |
|